PBE vs LCTD

Comparison between INVESCO BIOTECHNOLOGY & GENOME ETF (PBE, ETF) and BlackRock World ex U.S. Carbon Transition Readiness ETF (LCTD, ETF).

5-Year PerformanceLCTD has outperformed PBE, delivering a return of +7.2% compared to +4.2%

PBE vs LCTD - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	PBE(ETF)	LCTD(ETF)
Net Assets	$278M	$277M
Expense Ratio	0.58%	0.22%
Max Drawdown	45.69%	32.18%
Sharpe Ratio	1.70	0.85
5Y Beta	0.74	0.73
P/E Ratio	34.41	N/A
Forward P/E	20.14	N/A
5Y Dividends CAGR	N/A	57.14%
5Y EPS CAGR	10.60%	N/A
Debt to Equity	69.49%	N/A
P/S Ratio	4.61	N/A
P/B Ratio	4.44	N/A

Net Assets

Winner

PBE

$278M

LCTD

$277M

Expense Ratio

PBE

0.58%

Winner

LCTD

0.22%

Max Drawdown

PBE

45.69%

Winner

LCTD

32.18%

Sharpe Ratio

Winner

PBE

1.70

LCTD

0.85

5Y Beta

PBE

0.74

Winner

LCTD

0.73

P/E Ratio

PBE

34.41

LCTD

N/A

Forward P/E

PBE

20.14

LCTD

N/A

5Y Dividends CAGR

PBE

N/A

LCTD

57.14%

5Y EPS CAGR

PBE

10.60%

LCTD

N/A

Debt to Equity

PBE

69.49%

LCTD

N/A

P/S Ratio

PBE

4.61

LCTD

N/A

P/B Ratio

PBE

4.44

LCTD

N/A

PBE vs LCTD - Holdings Comparison

PBE and LCTD have 1 common holdings. Overlap is 0.00%

PBE's top 25 holdings weight is 88.24%. LCTD's top 25 holdings weight is 30.99%.

Rank	PBE	LCTD
#1	VERTEX PHARMACEUTICALS INC (VRTX) - 5.35%	ASML HOLDING NV COMMON STOCK EUR.09 (n/a) - 2.95%
#2	BIOGEN INC (BIIB) - 4.95%	ROYAL BANK OF CANADA COMMON STOCK (n/a) - 2.26%
#3	AMGEN INC (AMGN) - 4.92%	MSCI EAFE SEP26 IFUS 20260918 (n/a) - 1.59%
#4	ROYALTY PHARMA PLC CLASS A (RPRX) - 4.74%	NOVARTIS AG REGISTERED SHARES (n/a) - 1.55%
#5	ALNYLAM PHARMACEUTICALS INC (ALNY) - 4.68%	HSBC HOLDINGS PLC (n/a) - 1.37%
#6	REGENERON PHARMACEUTICALS INC (REGN) - 4.56%	n/a (n/a) - 1.28%
#7	GILEAD SCIENCES INC (GILD) - 4.34%	NESTLE SA (n/a) - 1.23%
#8	UNITED THERAPEUTICS CORP (UTHR) - 4.25%	ASTRAZENECA PLC (AZN:XLON) - 1.22%
#9	BIO-TECHNE CORP (TECH) - 3.56%	ENBRIDGE INC COMMON STOCK (n/a) - 1.19%
#10	CAREDX INC (CDNA) - 3.27%	BANCO SANTANDER SA (n/a) - 1.15%
#11	VERICEL CORP (VCEL) - 3.24%	BANK OF MONTREAL COMMON STOCK (n/a) - 1.14%
#12	PROTAGONIST THERAPEUTICS INC (PTGX) - 3.17%	SCHNEIDER ELECTRIC SE (n/a) - 1.10%
#13	ILLUMINA INC (ILMN) - 3.13%	GIVAUDAN SA (n/a) - 1.07%
#14	VERACYTE INC (VCYT) - 3.11%	SANOFI SA (n/a) - 1.07%
#15	REPLIGEN CORP (RGEN) - 2.98%	SIEMENS AG (n/a) - 1.06%
#16	PTC THERAPEUTICS INC (PTCT) - 2.97%	SAP SE (n/a) - 1.04%
#17	ACADIA PHARMACEUTICALS INC (ACAD) - 2.94%	AIA GROUP LTD (n/a) - 1.04%
#18	INCYTE CORP (INCY) - 2.90%	UBS GROUP AG REG COMMON STOCK USD.1 (n/a) - 1.02%
#19	BIOCRYST PHARMACEUTICALS INC (BCRX) - 2.80%	HITACHI LTD (n/a) - 1.01%
#20	HALOZYME THERAPEUTICS INC (HALO) - 2.79%	TOKYO ELECTRON LTD (n/a) - 1.01%
#21	SAREPTA THERAPEUTICS INC (SRPT) - 2.79%	INTESA SANPAOLO (n/a) - 0.99%
#22	QIAGEN NV (QGEN) - 2.72%	TORONTO DOMINION BANK COMMON STOCK (n/a) - 0.95%
#23	NEUROCRINE BIOSCIENCES INC (NBIX) - 2.70%	COMMONWEALTH BANK OF AUSTRALIA (n/a) - 0.90%
#24	EXELIXIS INC (EXEL) - 2.69%	ENGIE SA (n/a) - 0.90%
#25	BIOMARIN PHARMACEUTICAL INC (BMRN) - 2.69%	IBERDROLA SA (n/a) - 0.90%
Total Holdings	33	365

PBE vs LCTD - Historical Returns

Returns include dividend reinvestment.

Period	PBE	LCTD
1 month	+5.27%	+0.79%
3 months	+13.45%	+1.13%
6 months	+9.78%	+2.74%
1 year	+37.25%	+14.20%
5 years(CAGR)	+4.20%	+7.25%
10 years(CAGR)	+8.84%	N/A
Max(CAGR)	+9.24%	+7.59%

Winner

PBE

+5.27%

LCTD

+0.79%

Winner

PBE

+13.45%

LCTD

+1.13%

Winner

PBE

+9.78%

LCTD

+2.74%

Winner

PBE

+37.25%

LCTD

+14.20%

5Y(CAGR)

PBE

+4.20%

Winner

LCTD

+7.25%

10Y(CAGR)

PBE

+8.84%

LCTD

N/A

Max(CAGR)

Winner

PBE

+9.24%

LCTD

+7.59%

PBE vs LCTD - Annual Returns (2005 - 2026)

Returns include dividend reinvestment.

Year	PBE	LCTD
2026	+10.38%	+5.78%
2025	+23.76%	+30.57%
2024	-0.05%	+4.34%
2023	+4.60%	+16.30%
2022	-11.11%	-16.65%
2021	+1.21%	+4.37%
2020	+25.68%	N/A
2019	+18.35%	N/A
2018	-2.62%	N/A
2017	+20.54%	N/A
2016	-20.66%	N/A
2015	+1.36%	N/A
2014	+36.45%	N/A
2013	+57.53%	N/A
2012	+13.17%	N/A
2011	-7.24%	N/A
2010	+29.99%	N/A
2009	+19.16%	N/A
2008	-25.84%	N/A
2007	+6.24%	N/A
2006	+0.45%	N/A
2005	+17.45%	N/A

PBE vs LCTD Drawdown Comparison

The maximum drawdown for PBE was -45.69%, occurring on Mar 9, 2009. Recovery took 644 trading sessions.

The maximum drawdown for LCTD was -29.78%, occurring on Oct 12, 2022. Recovery took 629 trading sessions.

The current PBE drawdown is -3.48%. The current LCTD drawdown is -2.83%.

Rank	PBE	LCTD
#1	-45.69% Oct 15, 2007 - May 6, 2010	-29.78% Sep 3, 2021 - Mar 7, 2024
#2	-44.56% Jul 17, 2015 - Jul 20, 2020	-13.59% Sep 26, 2024 - May 2, 2025
#3	-37.84% Feb 8, 2021 - Nov 26, 2025	-10.92% Feb 26, 2026 - Mar 20, 2026
#4	-35.71% May 6, 2010 - Apr 2, 2013	-7.51% Jul 12, 2024 - Aug 19, 2024
#5	-21.12% Feb 27, 2006 - Apr 23, 2007	-5.57% Nov 12, 2025 - Dec 11, 2025
#6	-18.86% Feb 24, 2014 - Aug 25, 2014	-5.31% Jun 15, 2021 - Sep 2, 2021
#7	-14.38% Jul 20, 2020 - Nov 27, 2020	-4.54% Mar 13, 2024 - May 7, 2024
#8	-11.73% Jan 7, 2026 - Jun 23, 2026	-4.52% Jul 23, 2025 - Aug 15, 2025
#9	-10.65% Mar 19, 2015 - Jun 18, 2015	-3.66% Aug 30, 2024 - Sep 19, 2024
#10	-10.08% Sep 12, 2005 - Nov 17, 2005	-3.58% Jun 6, 2024 - Jul 11, 2024
#11	-9.07% Apr 25, 2007 - Sep 26, 2007	-3.48% Oct 6, 2025 - Oct 28, 2025
#12	-8.60% Aug 29, 2014 - Oct 23, 2014	-3.22% May 7, 2021 - May 24, 2021
#13	-7.84% May 28, 2013 - Jul 5, 2013	-2.68% Jun 12, 2025 - Jun 27, 2025
#14	-7.21% Nov 29, 2013 - Jan 7, 2014	-2.63% May 15, 2024 - Jun 6, 2024
#15	-6.59% Oct 2, 2013 - Oct 24, 2013	-2.55% Aug 22, 2025 - Sep 8, 2025

Correlation

Correlation between PBE and LCTD is 0.78 which considered as a strong positive correlation - the stocks tend to move together.

0.78

-101

Dividend Comparison (2009 - 2026)

PBE vs LCTD dividend yield comparison.

Year	PBE	LCTD
2026	0.99%	1.67%
2025	1.00%	3.61%
2024	0.05%	3.74%
2023	0.02%	3.16%
2022	0.00%	3.52%
2021	0.00%	2.20%
2020	0.04%	0.00%
2018	0.00%	0.00%
2017	0.57%	0.00%
2016	0.38%	0.00%
2015	1.12%	0.00%
2014	0.55%	0.00%
2009	0.45%	0.00%